These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4281429)

  • 1. Depressed endogenous fibrinolytic activity in essential hypertension.
    Tsapogas MJ; Peabody RA; Wu KT; Devaraj KT; Eckert C
    J Cardiovasc Surg (Torino); 1974; 15(6):651-4. PubMed ID: 4281429
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered endogenous fibrinolysis and biochemical factors in atherosclerosis.
    Peabody RA; Tsapogas MJ; Wu KT; Deveraj KT; Karmody AM; Eckert C
    Arch Surg; 1974 Aug; 109(2):309-13. PubMed ID: 4276947
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin.
    Worowski K; Prokopowicz J; Gabryelewicz A
    Haematologia (Budap); 1970; 4(3):399-403. PubMed ID: 4256949
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormalities in clotting and thrombolysis as a risk factor for stroke.
    Pilgeram LO
    Thromb Diath Haemorrh; 1974 May; 31(2):245-64. PubMed ID: 4850366
    [No Abstract]   [Full Text] [Related]  

  • 5. Resting levels of blood fibrinolysis in hyperlipoproteinemia.
    Brakman P; Astrup T; Levy RI; Fredrickson DS
    J Appl Physiol; 1974 Apr; 36(4):430-3. PubMed ID: 4274385
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormalities of fibrinolysis in essential hypertension.
    Ettenger MM; MacCarthy EP; Glas-Greenwalt P; Clyne DH; Pollak VE
    J Hypertens Suppl; 1984 Dec; 2(3):S175-8. PubMed ID: 6242555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the relationship between changes of blood lipids and the fibrinolytic picture in ambulatory patients with arteriosclerosis].
    Rugginenti A
    Minerva Med; 1974 May; 65(34):1873-7. PubMed ID: 4842771
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinolytic system of blood in patients with hypertensive disease].
    Fatkhullaev IF; Agapova LA
    Ter Arkh; 1974; 46(6):24-7. PubMed ID: 4279461
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in the fibrinolytic system of the blood in patients with hypertension with coronary arteriosclerosis and circulatory insufficiency].
    Aslanian NL; Dolabchian ZL; Shukhian VM; Demirchian AKh; Khachaturova IA
    Kardiologiia; 1972 Jul; 12(7):106-9. PubMed ID: 4670631
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical value of the measure of global fibrinolytic activity].
    Guillaume M; Zouaoui Boudjeltia K; Cauchie P; Hénuzet C
    Rev Med Brux; 2001 Apr; 22(2):A115-7. PubMed ID: 11388033
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes of haemostatic parameters in patients with acute cardioembolic stroke].
    Maksimova MIu; Domashenko MA; Ionova VG; Mikhal'chenko VN; Syskina EN; Okhtova FR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12 Pt 2):22-7. PubMed ID: 22792744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia.
    Epstein SE; Brakman P; Rosing DR; Redwood DR
    Lancet; 1970 Sep; 2(7674):631-4. PubMed ID: 4195770
    [No Abstract]   [Full Text] [Related]  

  • 13. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to "risk factors" for myocardial infarction.
    Korsan-Bengtsen K; Wilhelmsen L; Tibblin G
    Thromb Diath Haemorrh; 1972 Aug; 28(1):99-108. PubMed ID: 5074994
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plasminogen, antiplasmins and the rate of fibrinolysis in hypertension and atherosclerosis].
    Gritsiuk AI
    Kardiologiia; 1968 May; 8(5):54-8. PubMed ID: 5671692
    [No Abstract]   [Full Text] [Related]  

  • 15. Reproducibility in coagulation assays.
    Goldenfarb PB
    Am J Clin Pathol; 1971 May; 55(5):561-4. PubMed ID: 4253630
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrinolytic activity in Behçet's disease].
    Kogure M; Motoji K
    Nippon Ganka Gakkai Zasshi; 1972 Mar; 76(3):114-21. PubMed ID: 4261805
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analytical methods of study of the system of fibrinolysis (plasminogen proactivators-activators, plasminogen-plasmin, antiplasmins, antiactivators) (literature review)].
    Guseĭnov ChS; Golovastova GI; Gorelova AM; Cherenkova GM; Mikhailova ND
    Lab Delo; 1976; (5):276-83. PubMed ID: 62085
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correlative study of fibrinolysis and some indices of blood coagulation and lipid metabolism in arteriosclerotic disease].
    Craveri A; Repaci G; Cerrini R; Saracino F
    G Clin Med; 1969 Aug; 50(8):684-98. PubMed ID: 4243678
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the area of the chemical parameters during streptokinase infusion].
    Amery A; Vermylen J; Verstraete M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):7-19. PubMed ID: 4189377
    [No Abstract]   [Full Text] [Related]  

  • 20. Endogenous testosterone, fibrinolysis, and coronary heart disease risk in hyperlipidemic men.
    Glueck CJ; Glueck HI; Stroop D; Speirs J; Hamer T; Tracy T
    J Lab Clin Med; 1993 Oct; 122(4):412-20. PubMed ID: 8228555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.